Clinical trials
Blood Cancer clinical trials
Below are recruiting blood cancer clinical trials, each written for real people, not researchers. We’re tracking 462 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02087852Recruiting
Kidney cancer DNA registry for patients and family
This study collects DNA from adults with kidney cancer (or suspected kidney cancer), plus DNA from some family members and healthy controls. It helps researchers understand whether certain genetic changes might be linked to kidney cancer risk.
Basking Ridge, New JerseyAges 18 years+ - NCT06016569Recruiting
Breath test for early lung cancer in high-risk smokers
This study tests a new breath test to find early signs of lung cancer in people at high risk. It looks for cancer biomarkers in the air you breathe out. If you are a heavy smoker between 55 and 74, this trial may help detect lung cancer earlier.
BrnoAges 55–74 - NCT04113486Recruiting
NMAP protein in new kidney or liver tumors
This study looks at a protein called NMAP in people who have a new kidney or liver mass that will be surgically removed. It helps researchers understand how this protein relates to cancer and might lead to better tests or treatments in the future.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05199259Recruiting
Blood test study for people at risk for or with liver cancer
This trial tests a new blood test to help detect liver cancer (HCC) or confirm it’s not present in people with cirrhosis who are being monitored. It may help improve how doctors screen for liver cancer and decide who needs further imaging or treatment.
Escondido, CaliforniaAges 18 years+ - NCT06649474Recruiting
Oxaliplatin side effects linked to HMGB1 blood levels
This study checks if a substance called HMGB1 in your blood is linked to nerve damage and liver side effects from the chemotherapy drug oxaliplatin. It is for people with a specific type of stomach or pancreas cancer that can be surgically removed.
Clermont-FerrandAges 18 years+ - NCT04504747Recruiting
Real-time breast cancer testing during chemotherapy
This trial studies real-time molecular testing in people with breast cancer who are receiving chemotherapy before surgery. The goal is to learn how the cancer changes during treatment and whether this helps guide care around surgery and radiation.
Marseille, MarseilleAges 18 years+ - NCT02772367Recruiting
Make heart muscle cells from blood or skin in breast cancer
This study grows heart muscle cells from your blood or skin to better understand why some people develop heart problems from HER2 cancer treatments. You may be helping researchers learn how to predict and prevent treatment-related heart damage.
New York, New YorkAges 18 years+ - NCT06790797Recruiting
Predicting immunotherapy success in chest cancers
This study is for people with lung or esophageal cancer who will receive immunotherapy (drugs that help your immune system fight cancer). The researchers want to find markers in your blood and tumor that can predict how well the treatment will work.
Suzhou, JiangsuAges 18–80 - NCT07465848Recruiting
Testing telomere measurement to help diagnose lung cancer
This study uses a simple blood test to measure telomeres (parts of your DNA) to see if it can help detect lung cancer earlier. Researchers will compare results from people with lung cancer, heavy smokers, and low-risk individuals to improve diagnosis.
Elche, AlicanteAges 45 years+ - NCT06881550Enrolling by invitation
Herbal medicine study for women after breast cancer surgery
This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.
Shenyang, Chian/LiaoningAges 18–75 - NCT05443087Recruiting
Checking blood levels of targeted drugs for digestive cancers
This trial monitors how your prescribed targeted cancer medicine moves through your body by doing extra blood tests. The goal is to understand the drug’s levels and dosing in people with advanced digestive cancers, so treatment can be better managed.
AmiensAges 18 years+ - NCT05354765Recruiting
Collect immune cells by lymphapheresis to study cancer response
This trial studies how changing your immune system (with earlier treatments) affects cancer by collecting immune cells from your blood using a process called lymphapheresis. It may help researchers find better ways to monitor immune-related responses and side effects.
ParisAges 18 years+ - NCT07090291Recruiting
China colorectal cancer screening trial for adults 45–74
This trial is testing a new way to screen for colorectal cancer in adults aged 45 to 74. If you join, you will help researchers find better methods for early detection.
GuandongAges 45–74 - NCT02743858Recruiting
Watch swelling study after breast lymph node surgery
This study looks at how and when swelling (lymphedema) happens after breast cancer surgery on the armpit lymph nodes. You may be followed closely after your planned one-sided procedure to better understand who gets swelling and how it changes over time.
Basking Ridge, New JerseyAges 18 years+ - NCT04860453Recruiting
Family genetic testing study for patterns of different cancers
This study checks whether gene tests can help understand cancer risk in families where different relatives had different (discordant) cancers. It may help families and doctors better understand whether hereditary cancer risk is possible, even though some parts use routine standard care as a comparison group.
Cleveland, OhioAges 18–100 - NCT04522687Recruiting
Blood lymphocyte changes studied during radiation and chemotherapy for lung cancers
This study looks at how a type of white blood cell in your blood changes while you receive radiation and chemotherapy. The goal is to see whether these blood changes relate to treatment, especially in certain chest (thoracic) cancers.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07009288Recruiting
Time-restricted eating for childhood cancer survivors
This study looks at whether eating only during a set time each day can improve health in adults who survived childhood cancer. It may help with weight and related health issues.
New York, New YorkAges 18 years+ - NCT02474160Recruiting
Banking cancer tissue and blood for future research
This study collects and stores leftover or newly taken samples of tissue and blood from people with cancer. The goal is to build a research library that can help investigators study cancer and develop better tests or treatments.
Birmingham, AlabamaAges 2 months+ - NCT06305728Recruiting
New MRI scan and blood tests to find early signs of pancreatic cancer in people with IPMN
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
Basking Ridge, New JerseyAges 18 years+ - NCT04575363Recruiting
Testing a blood marker to predict pancreatic cancer outcomes
This study looks at a test called RPSA to see if it can help predict how pancreatic cancer may turn out. It includes people being treated at Reims University Hospital for pancreatic tumors that can be removed (or may become removable).
ReimsAges 18 years+ - NCT06241807RecruitingPhase 2
Camrelizumab plus chemo before surgery for stage III lung cancer
This trial tests adding the immunotherapy drug camrelizumab to standard chemotherapy before surgery for people with stage IIIA-IIIB non-small cell lung cancer. The goal is to see if this combination shrinks tumors more effectively before removal.
Jinan, ShandongAges 18–75 - NCT07769892Recruiting
Blood and stool test for digestive tract cancer screening
This study is testing a new way to screen for cancers of the digestive tract using a simple blood and stool test. It is for people who are already scheduled to have a digestive tract endoscopy, and it may help find cancers earlier without extra invasive procedures.
Zhaoqing, GuangdongAges 45–74 - NCT06626386Recruiting
Prostate cancer screening with a finger-prick test
This trial is testing a simple finger-prick blood test to measure prostate-specific antigen (PSA) for prostate cancer screening. It aims to make screening easier and more accessible.
Düsseldorf, North Rhine-WestphaliaAges 45–70 - NCT07626151Recruiting
Fluid Management During Robotic Prostate Surgery
This trial compares two approaches to giving IV fluids during robotic prostate removal surgery. Researchers will use a heart-monitoring device to guide one approach and want to see which method works better for patient recovery.
CairoAges 40–80
Hear when a new Blood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for blood cancer?
- Yes. Clin2 currently lists 462 recruiting blood cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a blood cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a blood cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.